Bristol Myers Squibb BMY
NYSE BMY
$62.93 -0.50 (-0.79%)
At close: Nov 16, 2026 · 4:00 PM EST

Bristol Myers Squibb (BMY) Free Cash Flow (2009 - 2026)

Updated

Bristol Myers Squibb (BMY) posted Free Cash Flow of $3.84 billion for Q3 2026, down 36.0% from $5.99 billion a year earlier but up 24.3% from the prior quarter.

Analysis

Bristol Myers Squibb (BMY) Free Cash Flow (2009 - 2026) Analysis & Trends

For the trailing twelve months through Sep 30, 2026, Free Cash Flow at Bristol Myers Squibb was $9.29 billion, down 39.3% year-over-year; for FY2025, it came in at $12.85 billion, down 7.9% from FY2024.

  • Annual Free Cash Flow shows a five-year compound annual growth rate of -0.7% (FY2020 to FY2025).
  • In prior years, Bristol Myers Squibb's Free Cash Flow was $13.94 billion in FY2024 (+10.2%), $12.65 billion in FY2023 (+5.9%), $11.95 billion in FY2022 (-21.6%) and $15.23 billion in FY2021 (+14.5%).
  • Quarterly Free Cash Flow has run from a low of $757 million in Q1 2026 to a high of $5.99 billion in Q3 2025 over five years.
  • On a year-over-year basis, Free Cash Flow has declined in each of the last four quarters, with an average decline of 13.6% over the last eight quarters.
  • The strongest year-over-year quarter for Free Cash Flow in the past five years was Q2 2025, with growth of 72.3%; the weakest was Q4 2025, with a decline of 60.5%.
  • According to Business Quant data, Free Cash Flow for the three prior quarters was $3.09 billion (Q2 2026), $757 million (Q1 2026) and $1.6 billion (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 8.22 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 6.36 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 7.31 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 5.52 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 7.96 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 3.65 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 4.80 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 4.80 Bn
10 Bristol Myers Squibb 128.63 Bn 83.82 Bn 8.92 Bn 3.84 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 3.84 Bn
Jun 30, 2026 3.09 Bn
Mar 31, 2026 757.00 Mn
Dec 31, 2025 1.60 Bn
Sep 30, 2025 5.99 Bn
Jun 30, 2025 3.56 Bn
Mar 31, 2025 1.69 Bn
Dec 31, 2024 4.06 Bn
Sep 30, 2024 5.27 Bn
Jun 30, 2024 2.06 Bn
Mar 31, 2024 2.55 Bn
Dec 31, 2023 3.92 Bn
Sep 30, 2023 4.41 Bn
Jun 30, 2023 1.63 Bn
Mar 31, 2023 2.69 Bn
Dec 31, 2022 2.96 Bn
Sep 30, 2022 3.44 Bn
Jun 30, 2022 1.99 Bn
Mar 31, 2022 3.56 Bn
Dec 31, 2021 3.74 Bn
API Access

Bristol Myers Squibb Free Cash Flow API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=free-cash-flow&ticker=BMY&period=max&api_key=YOUR_API_KEY